- Home
- INO vs BGX Comparison
INO vs BGX Comparison
Compare INO & BGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INO | BGX |
|---|---|---|
| Founded | 1979 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.6M | 151.0M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | INO | BGX |
|---|---|---|
| Price | $1.75 | $11.71 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 67.9K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.34% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $182,337.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $21,214.02 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.30 | $10.69 |
| 52 Week High | $2.98 | $12.44 |
Technical Indicators
Market Signals| Indicator | INO | BGX |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | 45.64 |
| Support Level | $2.11 | $11.65 |
| Resistance Level | $2.37 | $11.81 |
| Average True Range (ATR) | 0.19 | 0.16 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 6.16 | 77.39 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About BGX Blackstone Long Short Credit Income Fund
Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It seeks to achieve its investment objectives by employing a dynamic long-short strategies in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.